Dr. Ted Berei discusses the DAPA-HF trial and SGLT2 inhibitor therapy in patients with heart failure and reduced ejection fraction. Check out cardioscripts.com for episode show notes and references!

Dr. Ted Berei discusses the DAPA-HF trial and SGLT2 inhibitor therapy in patients with heart failure and reduced ejection fraction. Check out cardioscripts.com for episode show notes and references!

Dr. Ted Berei discusses the DAPA-HF trial and SGLT2 inhibitor therapy in patients with heart failure and reduced ejection fraction. Check out cardioscripts.com for episode show notes and references!

How sweet it is to be an SGLT2 Inhibitor

A cardiology pharmacy podcast hosted by Tracy Macaulay (@SchwietTMac) and Liz Sulaica (@val_smartan) with podcast editing by Nathan Wayne (@tweetlessnathan). For more updates, follow us on Twitter @CardioScripts and check out our website at https://cardioscripts.com/.

Share How sweet it is to be an SGLT2 Inhibitor

Sign up to save your podcasts

How sweet it is to be an SGLT2 Inhibitor

How sweet it is to be an SGLT2 Inhibitor